XML 33 R18.htm IDEA: XBRL DOCUMENT
v3.25.4

Debt and Derivatives | 12 Months Ended
--- | ---
Dec. 31, 2025
Debt Disclosure [Abstract] |
Debt and Derivatives | 6. Debt and Derivatives The table below summarizes the total outstanding debt of the Company (in thousands):
|  | December 31, 2025 |  |  | December 31, 2024 |
|  | Rate |  |  | Amount |  |  | Rate |  |  | Amount |
First Lien Incremental Term Loan Tranche B-5 - payable to lenders at SOFR plus applicable margin |  |  | 6.22 | % |  | $ | 2,521,255 |  |  |  | 6.86 | % |  | $ | 2,546,787 |
Revolving Credit Loans - payable to lenders at SOFR plus applicable margin |  |  | 6.47 | % |  |  | — |  |  |  | 7.61 | % |  |  | — |
Swingline/Base Rate - payable to lenders at ABR plus applicable margin |  |  | 8.50 | % |  |  | — |  |  |  | 9.75 | % |  |  | 63,300 |
Amortizing Notes (1) |  |  |  |  |  | 31,360 |  |  |  |  |  |  | 53,804 |
Notes payable and other |  |  |  |  |  | 17,129 |  |  |  |  |  |  | 19,428 |
Total debt |  |  |  |  |  | 2,569,744 |  |  |  |  |  |  | 2,683,319 |
Less: debt issuance costs, net |  |  |  |  |  | 62,200 |  |  |  |  |  |  | 72,736 |
Total debt, net of debt issuance costs |  |  |  |  |  | 2,507,544 |  |  |  |  |  |  | 2,610,583 |
Less: current portion of long-term debt |  |  |  |  |  | 52,340 |  |  |  |  |  |  | 48,725 |
Total long-term debt, net of current portion |  |  |  |  | $ | 2,455,204 |  |  |  |  |  | $ | 2,561,858 |
(1) See Note 7 for discussion of Amortizing Notes. |  |  |  |  |  |  |  |  |  |  |  |
As of December 31, 2025, maturities of long-term debt for the next five years and thereafter are as follows (in thousands):
2026 |  | $ | 52,340 |
2027 |  |  | 32,135 |
2028 |  |  | 40,549 |
2029 |  |  | 25,549 |
2030 |  |  | 25,549 |
Thereafter |  |  | 2,393,622 |
|  | $ | 2,569,744 |
See Note 13 for maturities of obligations under financing leases. The following discussion summarizes the debt agreements and related extinguishments and modifications for the years ended December 31, 2025 and 2024. Obligations under the First Lien Facility is guaranteed by Phoenix Guarantor, Inc., a subsidiary of the Company, and each of its current and future direct and indirect subsidiaries other than (among others) (i) foreign subsidiaries, (ii) unrestricted subsidiaries, (iii) non-wholly owned subsidiaries, (iv) certain receivables financing subsidiaries, (v) certain immaterial subsidiaries and (vi) certain holding companies of foreign subsidiaries, and are secured by a first lien on substantially all of their assets, including capital stock of subsidiaries. The current credit facilities described below contain customary negative covenants, including, but not limited to, restrictions on the Company and its restricted subsidiaries’ ability to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, make acquisitions, loans, advances or investments, pay dividends, sell or otherwise transfer assets, prepay or modify terms of certain junior indebtedness, enter into transactions with affiliates, or change their lines of business or fiscal year. In addition, the terms of the credit facilities will not permit the consolidated First Lien secured debt to consolidated earnings before interest, taxes, depreciation, and amortization (“EBITDA”) to be greater than 6.90 to 1.00, which shall be tested as of the end of the most recent quarter at any time when the aggregate Revolving Credit Facility loans exceed 35% of the total revolving credit commitments. We are required to disclose the fair value of financial instruments for which it is practicable to estimate the value, even though these instruments are not recognized at fair value in the consolidated balance sheets. The following table presents the estimated fair values of the Company’s debt obligations as of December 31, 2025 (in millions):
|  |  |  |  | Fair Value at Reporting Date Using |
Financial Instrument |  | Carrying Value as of December 31, 2025 |  |  | Markets for Identical Item (Level 1) |  |  | Significant Other Observable Inputs (Level 2) |  |  | Significant Unobservable Inputs (Level 3) |
First Lien Term Loan |  | $ | 2,521,255 |  |  | $ | — |  |  | $ | 2,540,164 |  |  | $ | — |
Amortizing Notes |  |  | 31,360 |  |  |  | — |  |  |  | 31,948 |  |  |  | — |
Total debt instruments |  | $ | 2,552,615 |  |  | $ | — |  |  | $ | 2,572,112 |  |  | $ | — |
First Lien Credit Agreement On March 5, 2019, the Company entered into a First Lien Credit Agreement (the “First Lien”), with Morgan Stanley Senior Funding, Inc., as the Administrative Agent and the Collateral Agent. The First Lien originally consisted of a principal amount of $1,650.0 million. In 2019, an additional delayed draw of $150.0 million was made on the First Lien, resulting in a gross borrowing of $1,800.0 million (“Tranche B-1”). Borrowings of Tranche B-1 Term Loans (as defined in the First Lien) under the First Lien bore interest at a rate equal to, at our option, (a) Secured Overnight Financing Rate (“SOFR”) (with a floor of 0.00%) plus 3.25% or (b) Alternate Base Rate (“ABR”) plus 2.25%. Principal payments were due on the last business day of each quarter, commencing in September 2019 at 0.25% of the aggregate principal of the original loan amount, with a balloon payment due in March 2026. The First Lien, as amended in 2020, established a Tranche B-2 Term Loan (“Tranche B-2”) in an aggregate principal amount equal to $550.0 million. The First Lien, as amended in 2021, established a Tranche B-3 Term Loan (“Tranche B-3”) in an aggregate principal amount equal to $675.0 million. Borrowings under Tranche B-2 and Tranche B-3, bore interest at a rate equal to, at our option, (a) SOFR (with a floor of 0.00%) plus 3.50% or (b) ABR plus 2.50%. Principal payments were due on the last business day of each fiscal quarter, commencing in June 2021 at 0.25% of the aggregate principal of the original loan amount, with a balloon payment due in March 2026. On February 21, 2024, we used a portion of the net proceeds received from the IPO Offerings to repay $343.3 million of the borrowings under the First Lien, and amended the First Lien to establish a new Tranche B-4 Term Loan (“Tranche B-4”) in an aggregate principal amount of $2,566.0 million. The proceeds from Tranche B-4 borrowings were used to refinance the equivalent amount of the remaining First Lien Tranches B-1, B-2, and B-3 borrowings at a rate equal to SOFR plus 3.25% with a maturity date of February 21, 2031. The transaction was accounted for as a debt modification. Principal payments were due on the last business day of each quarter, which commenced in the second fiscal quarter of 2024 and equated to 0.25% of the principal at issuance, with a balloon payment due in February 2031. On December 11, 2024, we amended the First Lien to refinance Tranche B-4 by establishing a Tranche B-5 Term Loan (“Tranche B-5”) in an aggregate principal amount of $2,553.2 million at a rate equal to, at our option, (a) SOFR plus 2.50% or (b) ABR plus 1.50% with a maturity date of February 21, 2031. The non-cash transaction was accounted for as a debt modification. Principal payments are due on the last business day of each quarter, which commenced in the first fiscal quarter of 2025 and equate to 0.25% of the principal at issuance, with a balloon payment due in February 2031. Revolving Credit Facility The First Lien also extends credit in the form of Revolving Credit Facility with a borrowing capacity of $475.0 million (the “Revolver”), of which up to $50.0 million is available as swingline loans and up to $82.5 million is available as letters of credit (the “LC Sublimit”). The Revolver will mature on June 30, 2028. In connection with the First Lien modification on February 21, 2024, borrowings of the Revolver bear interest at a rate equal to SOFR (with a floor of 0.00%) plus 3.25% for the Revolving Credit Loans or ABR plus 2.25% for the Swingline Loans. As of December 31, 2025, the Company had $475.0 million of borrowing capacity available under the Revolver as there were no borrowings under the Revolver or letters of credit outstanding. As of December 31, 2024, the Company had $63.3 million of borrowings outstanding under the Revolver and no letters of credit reducing the available borrowing capacity to approximately $411.7 million. The Company’s First Lien also provides for an additional letter of credit commitments (the “LC Facility”), which are not subject to the LC Sublimit and do not reduce the Revolver borrowing capacity. On September 17, 2024, the Company amended the First Lien to increase the LC Facility from $55.0 million to $65.0 million. As of December 31, 2025 and 2024, there were $62.8 million and $61.8 million of letters of credit outstanding under the LC Facility, respectively, resulting in an available borrowing capacity of $2.2 million and $3.2 million, respectively. Second Lien Credit Agreement The Company’s amended and restated Second Lien Credit Agreement (the “Second Lien Facility”), with certain Lenders and Wilmington Trust, National Association, as the Administrative Agent and the Collateral Agent consisted of a principal amount of $450.0 million. Borrowings under the Second Lien Facility term were subordinated to the First Lien and bore interest at a rate equal to, at our option, (a) SOFR (with a floor of 1.00%) plus 8.50% or (b) ABR plus 7.50%. The aggregate principal was due with a balloon payment in March 2027. On January 30, 2024, we used a portion of the net proceeds received from the IPO Offerings to repay all outstanding borrowings under the Second Lien Facility. No remaining obligation exists related to the Second Lien Facility. This transaction was accounted for as a debt extinguishment and the Company incurred a loss on extinguishment of debt of $12.7 million related to the write-off of unamortized debt issuance costs during the first fiscal quarter of 2024. Derivative Financial Instruments To manage fluctuations in cash flows resulting from changes in the variable rates, the Company entered into receive-variable, pay-fixed interest rate swap agreements. Taken together with the related debt, these swaps create the economic equivalent of fixed-rate debt, up to the notional amount of the hedged debt. By using a derivative instrument to hedge exposures to changes in interest rates, we expose ourselves to credit risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is negative, the Company owes the counterparty and, therefore, the Company is not exposed to the counterparty’s credit risk in those circumstances. The Company mitigates counterparty credit risk in derivative instruments by entering into transactions with high-quality counterparties. The derivative instruments entered into by the Company do not contain credit-risk-related contingent features. The following table summarizes our interest rate swaps designated as cash flow hedges (in millions):
|  | Notional Amount as of |  |  |  |  |  |
Financial Institution |  | December 31, 2025 |  |  | December 31, 2024 |  |  | Effective Dates |  | Fixed Rates |
Credit Suisse |  | $ | — |  |  | $ | 500 |  |  | 3-year period ending September 30, 2025 |  |  | 3.41650 | %
Morgan Stanley |  |  | — |  |  |  | 1,050 |  |  | 3-year period ending September 30, 2025 |  |  | 3.42000 | %
Credit Agricole Corporate and Investment Bank |  |  | — |  |  |  | 450 |  |  | 3-year period ending September 30, 2025 |  |  | 3.52410 | %
Matured contracts |  | $ | — |  |  | $ | 2,000 |  |  |  |  |  |
Credit Agricole Corporate and Investment Bank |  | $ | 500 |  |  | $ | — |  |  | 1-year period ending September 30, 2026 |  |  | 3.72500 | %
Mizuho Capital Markets |  |  | 500 |  |  |  | — |  |  | 1-year period ending September 30, 2026 |  |  | 3.61121 | %
Credit Agricole Corporate and Investment Bank |  |  | 250 |  |  |  | — |  |  | 3-year period ending September 30, 2028 |  |  | 3.33150 | %
Morgan Stanley |  |  | 250 |  |  |  | — |  |  | 3-year period ending September 30, 2028 |  |  | 3.17700 | %
Existing contracts |  | $ | 1,500 |  |  | $ | — |  |  |  |  |  |
Mizuho Capital Markets |  | $ | 500 |  |  | $ | — |  |  | 2-year period ending September 30, 2028 |  |  | 3.20220 | %
Forward starting contracts (1) |  | $ | 500 |  |  | $ | — |  |  |  |  |  |
(1) During the fourth fiscal quarter of 2025, we entered into a forward starting interest rate swap agreement, with a $500 million notional amount, to hedge the cash flow risk of variability in interest payment on our variable rate borrowings. The effective date of the forward starting interest rate swap agreement is September 30, 2026. As of December 31, 2025, this contract meets the criteria of a cash flow hedge. The net fair value of the cash flow hedges as of December 31, 2025 and 2024 was $0.4 million liability and $10.6 million asset, respectively, and is reflected in prepaid expenses and other current assets, other assets, accrued expenses, and long-term liabilities in the consolidated balance sheets. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. Interest received, including payments made or received under the cash flow hedges, was $15.2 million, $35.3 million, and $31.4 million for the years ended December 31, 2025, 2024, and 2023, respectively. During the next twelve months, the Company expects approximately $0.8 million of losses will be reclassified into pre-tax earnings out of AOCI.

X
- Definition Debt disclosure and derivative financial instruments. + References No definition available. + Details
Name: | btsg_DebtDisclosureAndDerivativeFinancialInstrumentsTextBlock
Namespace Prefix: | btsg_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DebtDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration